Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
51 studies found for:    Open Studies | "Hyperthyroidism"
Show Display Options
Rank Status Study
21 Recruiting K1-70 - A Study in Subjects With Graves' Disease
Condition: Graves' Disease
Intervention: Drug: K1-70 intramuscular
22 Recruiting The Association Between Autoimmune or Inflammation and Thyroid Disease
Condition: THYROTOXICOSIS
Intervention:
23 Recruiting Celecoxib for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Celecoxib;   Drug: artificial tears
24 Recruiting Graves' Orbitopathy and Hypercholesterolemia
Conditions: Graves' Ophthalmopathy;   Hypercholesterolemia
Intervention: Other: No intervention
25 Recruiting A Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease
Condition: Rrelapsed Graves' Disease
Intervention: Device: HIFU Graves
26 Recruiting The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
Condition: Mild Graves' Ophthalmopathy
Interventions: Drug: Metformin;   Drug: Placebo
27 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Condition: Thyroid Eye Disease
Interventions: Drug: Methylprednisolone + ASTED;   Drug: Methylprednisolone +Placebo
28 Recruiting mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX)
Condition: Dysthyroid Ophthalmopathies
Intervention:
29 Not yet recruiting The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
Condition: Thyroid Eye Disease
Interventions: Drug: ASTED;   Dietary Supplement: Selenium;   Other: Placebo
30 Recruiting D-vitamin And Graves' Disease; Morbidity And Relapse Reduction
Condition: Graves' Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
31 Recruiting Rituximab (RTX) Therapy in Patients With Active TAO
Condition: Ophthalmopathy, Thyroid-Associated
Interventions: Drug: Rituximab;   Drug: Iv Methylprednisolone;   Drug: peroral methylprednisolone and Methotrexate
32 Not yet recruiting Role of the Microbiome in Graves' Orbitopathy
Condition: Graves' Disease
Intervention: Biological: LAB4
33 Not yet recruiting Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease
Condition: Graves Ophthalmopathy
Interventions: Radiation: External beam radiotherapy;   Drug: intravenous corticosteroids (methylprednisolone)
34 Recruiting B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condition: Thyroid Eye Disease
Intervention:
35 Recruiting Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People
Condition: Graves' Ophthalmopathy
Intervention:
36 Not yet recruiting Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Condition: Graves Disease
Intervention:
37 Recruiting Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
Condition: Thyroid Associated Ophthalmopathies
Intervention: Drug: bimatoprost 0.03%
38 Unknown  Selenium in Mild Thyroid Eye Disease in North America
Condition: Thyroid Associated Ophthalmopathies
Interventions: Dietary Supplement: Sodium selenite;   Dietary Supplement: Sugar pill
39 Unknown  Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy
Condition: Graves Ophthalmopathy
Interventions: Procedure: blepharotomy;   Procedure: posterior approach
40 Unknown  A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy
Condition: Graves' Ophthalmopathy
Intervention: Drug: methylprednisolone, prednisone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-51) Show next page of results    Last Page
Indicates status has not been verified in more than two years